Clinical Trial Update: Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nivolumab and ipilimumab in combination with chemoradiation for resectable gastric cancer and gastroesophageal junction aden…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING